Sarepta Therapeutics (SRPT) Assets (2010 - 2026)
Sarepta Therapeutics (SRPT) recorded Assets of $3.19 billion in Q2 2026, down 13.4% from $3.68 billion a year earlier but up 0.3% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Sarepta Therapeutics reported Assets of $3.35 billion, down 15.5% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $3.96 billion in FY2024 (+21.4%), $3.26 billion in FY2023 (+4.4%), $3.13 billion in FY2022 (-0.6%) and $3.15 billion in FY2021 (+5.5%).
- Quarterly Assets has ranged from $2.66 billion in Q3 2021 to $3.96 billion in Q4 2024 over the past five years.
- On a year-over-year basis, Assets has declined for four consecutive quarters, with growth averaging 1.5% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 21.4% in Q4 2024, against a decline of 15.5% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.18 billion (Q1 2026), $3.35 billion (Q4 2025) and $3.49 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Sarepta Therapeutics | 1.79 Bn | -1.47 Bn | 192.84 Mn | 3.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.17 Bn |
| Jun 30, 2026 | 3.19 Bn |
| Mar 31, 2026 | 3.18 Bn |
| Dec 31, 2025 | 3.35 Bn |
| Sep 30, 2025 | 3.49 Bn |
| Jun 30, 2025 | 3.68 Bn |
| Mar 31, 2025 | 3.47 Bn |
| Dec 31, 2024 | 3.96 Bn |
| Sep 30, 2024 | 3.60 Bn |
| Jun 30, 2024 | 3.42 Bn |
| Mar 31, 2024 | 3.22 Bn |
| Dec 31, 2023 | 3.26 Bn |
| Sep 30, 2023 | 3.11 Bn |
| Jun 30, 2023 | 3.13 Bn |
| Mar 31, 2023 | 3.06 Bn |
| Dec 31, 2022 | 3.13 Bn |
| Sep 30, 2022 | 3.16 Bn |
| Jun 30, 2022 | 3.00 Bn |
| Mar 31, 2022 | 3.06 Bn |
| Dec 31, 2021 | 3.15 Bn |
API Access
Sarepta Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();